The leading Migraine Companies such as ​ Satsuma Pharmaceuticals, Biohaven Pharmaceuticals, Allodynic Therapeutics, Vaxxinity ...

This market research report provides an in-depth analysis of the Injectable Drug Delivery Market, projecting significant growth from 2025 to 2035. The global market is expected to expand from USD 704.

The global generic drugs market size has been calculated at $468.08 billion in 2025 and is estimated to be worth $728.64 ...

As per Future Market Insights’ latest industry analysis, the valuation for the global clot busting drugs market is estimated to be around USD 28.8 Billion in 2022 and is projected to exhibit a CAGR ...

“The oral medications will bring other people into the system ... The fact we’re going down this route fills me with dread.” Such a “grey market” for weight loss medicines is inevitable as their price ...

The Drug Delivery Devices Market segmentation, based on route of administration, includes oral, ocular, inhalation, nasal, injectable, topical, and others. Oral segment dominated the global market in ...

The IN route potentially improves systemic bioavailability of drugs since it bypasses gastrointestinal ... hydrochloride (HCl), and the effect of an oral decongestant (pseudoephedrine) or nasal ...

The global rheumatoid arthritis drugs market was valued at $57,929 million in 2019, and is projected to reach $62,935 million by 2027, registering a CAGR of 2.8% from 2020 to 2027. Alarming rise in ...

In her practice, though, the injectable route has not been a deterrent to getting patients ... Given the availability of an oral medication and injectable, Lala asked how prescribers should proceed ...

NTNU researchers identified an oral antiviral cocktail that blocks enterovirus replication in human cells and mini-organs. The combination, previously tested for safety, showed no adverse effects on ...

Ascletis is taking a low and slow approach to oral GLP-1 dose titration in a phase 2a test after getting a look at clinical ...

Asthma Drugs Market Oral and injectable forms are expanding, especially for patients with severe asthma and those undergoing biologic treat ...